Literature DB >> 17261681

Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa.

M H Wong1, K Robertson, N Nakasujja, R Skolasky, S Musisi, E Katabira, J C McArthur, A Ronald, N Sacktor.   

Abstract

OBJECTIVE: To measure the frequency and associated risk factors of HIV dementia in an HIV clinic in Kampala, Uganda.
METHODS: We systematically sampled 78 HIV-seropositive (HIV+) patients from an ambulatory HIV clinic. Participants underwent detailed sociodemographic, medical history, functional, neurologic, and neuropsychological evaluations. One hundred HIV-negative patients were recruited to provide normative data for the neuropsychological tests. A logistic regression model was constructed to determine risk factors associated with the diagnosis of HIV dementia.
RESULTS: Thirty-one percent (24 of 78) of the HIV+ patients had HIV dementia. Advanced age and low CD4(+) T-lymphocyte count (CD4 count) were the only variables identified as significant risk factors in the logistic regression model. Each additional 10 years of age conferred a greater than twofold risk of HIV dementia (OR 2.06, 95% CI: 1.05 to 4.07; p < 0.05). Reduced levels of CD4 count (100 cells/muL decrement) was associated with a 60% increase in the odds of having HIV dementia (OR 1.6, 95% CI: 1.04 to 2.33; p < 0.05).
CONCLUSION: HIV dementia is common in HIV-seropositive Ugandan individuals attending an AIDS clinic. It is more frequently associated with patients of advanced age and decreased CD4 count.

Entities:  

Mesh:

Year:  2007        PMID: 17261681     DOI: 10.1212/01.wnl.0000252811.48891.6d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  58 in total

Review 1.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

2.  Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study.

Authors:  Renee Donahue Carlson; Melissa A Rolfes; Kate E Birkenkamp; Noeline Nakasujja; Radha Rajasingham; David B Meya; David R Boulware
Journal:  Metab Brain Dis       Date:  2014-01-09       Impact factor: 3.584

3.  Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China.

Authors:  Lucette A Cysique; Scott L Letendre; Christopher Ake; Hua Jin; Donald R Franklin; Saurabh Gupta; Chuan Shi; Xin Yu; Zunyou Wu; Ian S Abramson; Igor Grant; Robert K Heaton
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

Review 4.  Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.

Authors:  William Tyor; Cari Fritz-French; Avindra Nath
Journal:  J Neurovirol       Date:  2013-10-16       Impact factor: 2.643

5.  Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Authors:  Viktor Dahl; Julia Peterson; Dietmar Fuchs; Magnus Gisslen; Sarah Palmer; Richard W Price
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

6.  Monocyte activation, HIV, and cognitive performance in East Africa.

Authors:  L Arnoldo Muñoz-Nevárez; Brandon M Imp; Michael A Eller; Francis Kiweewa; Jonah Maswai; Christina Polyak; Omalla Allan Olwenyi; I Elaine Allen; Eric Rono; Benedetta Milanini; Hannah Kibuuka; Julie A Ake; Leigh Anne Eller; Victor G Valcour
Journal:  J Neurovirol       Date:  2019-08-29       Impact factor: 2.643

7.  Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China.

Authors:  Robert K Heaton; Lucette A Cysique; Hua Jin; Chuan Shi; Xin Yu; Scott Letendre; Donald R Franklin; Christopher Ake; Ofilio Vigil; J Hampton Atkinson; Thomas D Marcotte; Igor Grant; Zunyou Wu
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

8.  Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.

Authors:  Kathy Lawler; Mosepele Mosepele; Sarah Ratcliffe; Esther Seloilwe; Katherine Steele; Rudo Nthobatsang; Andrew Steenhoff
Journal:  J Int AIDS Soc       Date:  2010-04-20       Impact factor: 5.396

9.  HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon.

Authors:  Georgette D Kanmogne; Callixte T Kuate; Lucette A Cysique; Julius Y Fonsah; Sabine Eta; Roland Doh; Dora M Njamnshi; Emilienne Nchindap; Donald R Franklin; Ronald J Ellis; John A McCutchan; Fidele Binam; Dora Mbanya; Robert K Heaton; Alfred K Njamnshi
Journal:  BMC Neurol       Date:  2010-07-13       Impact factor: 2.474

10.  Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.

Authors:  Noeline Nakasujja; Richard L Skolasky; Seggane Musisi; Peter Allebeck; Kevin Robertson; Allan Ronald; Elly Katabira; David B Clifford; Ned Sacktor
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.